165 related articles for article (PubMed ID: 22006624)
1. [Nanomedicine as the basis of personalised medicine].
Wojnicz R
Kardiol Pol; 2011; 69(10):1107-8. PubMed ID: 22006624
[TBL] [Abstract][Full Text] [Related]
2. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
[TBL] [Abstract][Full Text] [Related]
3. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
4. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
Elder JB; Liu CY; Apuzzo ML
Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
[TBL] [Abstract][Full Text] [Related]
5. A perspective of nanotechnology in hypersensitivity reactions including drug allergy.
Montañez MI; Ruiz-Sanchez AJ; Perez-Inestrosa E
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):297-302. PubMed ID: 20485158
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
Eifler AC; Thaxton CS
Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology in cardiovascular medicine.
Patel DN; Bailey SR
Catheter Cardiovasc Interv; 2007 Apr; 69(5):643-54. PubMed ID: 17390307
[TBL] [Abstract][Full Text] [Related]
8. Nanobiotechnology and personalized medicine.
Jain KK
Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
[TBL] [Abstract][Full Text] [Related]
9. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
Cabral H; Nishiyama N; Kataoka K
Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
[TBL] [Abstract][Full Text] [Related]
10. Emerging trends of nanomedicine--an overview.
Sandhiya S; Dkhar SA; Surendiran A
Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
12. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in basic and clinical nanomedicine.
Morrow KJ; Bawa R; Wei C
Med Clin North Am; 2007 Sep; 91(5):805-43. PubMed ID: 17826104
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine-based strategies for treatment of atherosclerosis.
Schiener M; Hossann M; Viola JR; Ortega-Gomez A; Weber C; Lauber K; Lindner LH; Soehnlein O
Trends Mol Med; 2014 May; 20(5):271-81. PubMed ID: 24594264
[TBL] [Abstract][Full Text] [Related]
15. Future approaches of nanomedicine in clinical science.
Brewer M; Zhang T; Dong W; Rutherford M; Tian ZR
Med Clin North Am; 2007 Sep; 91(5):963-1016. PubMed ID: 17826113
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine and society.
Ferrari M; Philibert MA; Sanhai WR
Clin Pharmacol Ther; 2009 May; 85(5):466-7. PubMed ID: 19381150
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies.
Miossec P; Verweij CL; Klareskog L; Pitzalis C; Barton A; Lekkerkerker F; Reiter S; Laslop A; Breedveld F; Abadie E; Flamion B; Dere W; Mpofu S; Goel N; Ethgen D; Mitlak B; Ormarsdóttir S; Rao R; Tsouderos Y; Reginster JY;
Ann Rheum Dis; 2011 Oct; 70(10):1713-8. PubMed ID: 21784723
[TBL] [Abstract][Full Text] [Related]
19. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery.
Leary SP; Liu CY; Apuzzo ML
Neurosurgery; 2006 Jun; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880
[TBL] [Abstract][Full Text] [Related]
20. Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level.
Leary SP; Liu CY; Apuzzo ML
Neurosurgery; 2006 May; 58(5):805-23; discussion 805-23. PubMed ID: 16639314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
